✦ LIBER ✦

Evaluation of a Series of Naphthamides as Potent, Orally Active Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitors ¶

✍ Scribed by Weiss, Matthew M.; Harmange, Jean-Christophe; Polverino, Anthony J.; Bauer, David; Berry, Loren; Berry, Virginia; Borg, George; Bready, James; Chen, Danlin; Choquette, Deborah; Coxon, Angela; DeMelfi, Tom; Doerr, Nicholas; Estrada, Juan; Flynn, Julie; Graceffa, Russell F.; Harriman, Shawn P.; Kaufman, Stephen; La, Daniel S.; Long, Alexander; Neervannan, Sesha; Patel, Vinod F.; Potashman, Michele; Regal, Kelly; Roveto, Phillip M.; Schrag, Michael L.; Starnes, Charlie; Tasker, Andrew; Teffera, Yohannes; Whittington, Douglas A.; Zanon, Roger

Book ID: 126101608
Publisher: American Chemical Society
Year: 2008
Tongue: English
Weight: 777 KB
Volume: 51
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm701098w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design, Synthesis, and Evaluation of Ora

Design, Synthesis, and Evaluation of Orally Active Benzimidazoles and Benzoxazoles as Vascular Endothelial Growth Factor-2 Receptor Tyrosine Kinase Inhibitors

✍ Potashman, Michele H.; Bready, James; Coxon, Angela; DeMelfi,, Thomas M.; DiPiet 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 673 KB

Design, Synthesis, and Evaluation of Ora

Design, Synthesis, and Evaluation of Orally Active Benzimidazoles and Benzoxazoles as Vascular Endothelial Growth Factor-2 Receptor Tyrosine Kinase Inhibitors

✍ Potashman, Michele H.; Bready, James; Coxon, Angela; DeMelfi, Thomas M.; DiPietr 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 29 KB

ZM323881, a Novel Inhibitor of Vascular

ZM323881, a Novel Inhibitor of Vascular Endothelial Growth Factor-Receptor-2 Tyrosine Kinase Activity

✍ C.E. WHITTLES; T.M. POCOCK; S.R. WEDGE; J. KENDREW; L.F. HENNEQUIN; S.J. HARPER; 📂 Article 📅 2002 🏛 Informa plc 🌐 English ⚖ 253 KB

A highly selective, orally bioavailable,

A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivo

✍ Kenneth R. LaMontagne; Jeannene Butler; Virna B. Borowski; Angel R. Fuentes-Pesq 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 432 KB

KRN951, a Highly Potent Inhibitor of Vas

KRN951, a Highly Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Has Antitumor Activities and Affects Functional Vascular Properties

✍ Nakamura, K. 📂 Article 📅 2006 🏛 American Association for Cancer Research 🌐 English ⚖ 423 KB

A novel pyrrolo[3, 2-d]pyrimidine deriva

A novel pyrrolo[3, 2-d]pyrimidine derivative, as a vascular endothelial growth factor receptor and platelet-derived growth factor receptor tyrosine kinase inhibitor, shows potent antitumor activity by suppression of tumor angiogenesis

✍ Yoshiko Awazu; Akio Mizutani; Yoshinori Nagase; Hidehisa Iwata; Yuya Oguro; Hiro 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB